Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "A16A" (164)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
What is an ATC-Code?
ATC-Overview
Levocarnitine (A16AA01) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
Carnitene 1.0 g/5.0 ml
5
20.07
38.25
10 %
Injection solution: Levocarnitinum
Alfasigma Schweiz AG
B / SL
FB
G
L
IP
CI
Carnitene
30
93.13
117.70
10 %
Chewing tablets: Levocarnitinum 1 g
Alfasigma Schweiz AG
B / SL
FB
G
L
IP
CI
Carnitene 1 g/10 ml
10 x 10 ml
19.69
37.85
10 %
Solution (oral): Levocarnitinum
Alfasigma Schweiz AG
B / SL
FB
G
IP
CI
Carnitene
40 ml
k.A.
Sirup: Levocarnitinum
Alfasigma Schweiz AG
B
FB
G
Mercaptamine (A16AA04) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Procysbi 25 mg
60
329.25
374.50
10 %
gélules gastro-résistantes: Mercaptaminum 25 mg
Chiesi SA
B / SL
FB
G
L
IP
CI
Procysbi 75 mg
250
4115.63
4492.40
10 %
gélules gastro-résistantes: Mercaptaminum 75 mg
Chiesi SA
B / SL
FB
G
Carglumic Acid (A16AA05) 2 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Carbaglu 200 mg
5
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mg
Recordati AG
B
FB
G
IP
CI
Carbaglu 200 mg
60
k.A.
Tabletten zur Herstellung einer Suspension zum Einnehmen: Acidum Carglumicum 200 mg
Recordati AG
B
FB
G
Imiglucerase (A16AB02) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Cerezyme 400 U
Durchstechflasche(n)
1511.85
1660.65
10 %
poudre pour solution à diluer pour perfusion: Imiglucerasum 400 U
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
Agalsidase Alfa (A16AB03) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Replagal
Durchstechflasche(n)
1787.89
1960.85
10 %
Concentrate for infusion: Agalsidasum Alfa 1 mg
Takeda Pharma AG
A / SL
FB
G
Agalsidase Beta (A16AB04) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
SIP
IP
Fabrazyme 5 mg
478.32
536.60
10 %
poudre pour solution à diluer pour perfusion: Agalsidasum Beta 5 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
SIP
IP
CI
Fabrazyme 35 mg
Durchstechflasche(n)
3348.27
3657.85
10 %
poudre pour solution à diluer pour perfusion: Agalsidasum Beta 35 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
Alglucosidase Alfa (A16AB07) 2 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
SIP
IP
Myozyme
Durchstechflasche(n)
484.34
514.35
10 %
Poudre pour solution à diluer pour perfusion: Alglucosidasum Alfa 50 mg
Sanofi-Aventis
(Suisse) SA
A / SL
FB
G
SIP
IP
Myozyme
25 Durchstechflasche(n)
k.A.
Poudre pour solution à diluer pour perfusion: Alglucosidasum Alfa 50 mg
Sanofi-Aventis
(Suisse) SA
A
FB
G
Galsulfase (A16AB08) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
SIP
IP
Naglazyme
Durchstechflasche(n) à 5 ml
1329.67
1462.50
10 %
Concentrate for infusion: Galsulfasum 5 mg
DRAC AG
B / SL
FB
G
Idursulfase (A16AB09) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
SIP
IP
CI
Elaprase
Durchstechflasche(n)
2580.22
2822.55
10 %
Concentrate for infusion: Idursulfasum 2 mg/ml
Takeda Pharma AG
A / SL
FB
G
Elosulfase Alfa (A16AB12) 1 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
Vimizim 5mg/5ml
Durchstechflasche(n)
k.A.
Concentrate for infusion: Elosulfasum Alfa 5mg / 5ml
DRAC AG
B
FB
G
Asfotase Alfa (A16AB13) 20 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 40 mg/ml
12
k.A.
Injection solution: Asfotasum Alfa 40 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
IP
CI
PP
Strensiq 100 mg/ml
k.A.
Injection solution: Asfotasum Alfa 100 mg/ml
Alexion Pharma GmbH
A
FB
G
Pegunigalsidase Alfa (A16AB20) 3 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
Elfabrio 20 mg/10 ml
1864.18
2043.80
10 %
Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A / SL
FB
G
IP
Elfabrio 20 mg/10 ml
5
k.A.
Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A
FB
G
IP
Elfabrio 20 mg/10 ml
10
k.A.
Concentrate for infusion: Pegunigalsidasum Alfa 20mg / 10ml
Chiesi SA
A
FB
G
Anethole Trithione (A16AX02) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Sulfarlem S 25
60 Dragée(s)
k.A.
Dragées: Anetholtrithionum 25 mg
Recordati AG
D
FB
G
Sodium Phenylbutyrate (A16AX03) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
Pheburane 483 mg/g
430.03
484.10
10 %
Granulat zur Herstellung einer Lösung zum Einnehmen: Natrii Phenylbutyras 483 mg
Medius AG
B / SL
FB
G
Nitisinone (A16AX04) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
IP
CI
Nitisinon NOBEL 5 mg
60
k.A.
Capsules: Nitisinonum 5 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Nitisinon NOBEL 10 mg
60
k.A.
Capsules: Nitisinonum 10 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Nitisinon NOBEL 20 mg
60
k.A.
Capsules: Nitisinonum 20 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Nitisinon NOBEL 4 mg/ml
100 ml
k.A.
Suspension: Nitisinonum 4 mg/ml
NOBEL Pharma Schweiz AG
B
FB
G
Miglustat (A16AX06) 4 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Zavesca
84 Capsule(s)
4501.01
4883.85
10 %
Capsules: Miglustatum 100 mg
Janssen-Cilag AG
B / SL / SO
FB
G
L
IP
CI
Miglustat Dipharma 100 mg
84
4050.91
4422.00
10 %
Capsules: Miglustatum 100 mg
Dipharma SA
B / SL / SG
FB
G
L
IP
CI
Opfolda 65 mg
4
167.63
198.70
10 %
Capsules: Miglustatum 65 mg
Amicus Therapeutics
Switzerland GmbH
B / SL
FB
G
L
IP
CI
Opfolda 65 mg
24
1005.78
1110.25
10 %
Capsules: Miglustatum 65 mg
Amicus Therapeutics
Switzerland GmbH
B / SL
FB
G
Sapropterin (A16AX07) 11 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Sapropterin Spirig HC 100 mg
30
851.18
940.80
10 %
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Sapropterin Spirig HC 100 mg
120
2791.88
3052.75
10 %
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Sapropterin Dipharma 100 mg
30
851.18
940.80
10 %
compressa dispersibile: Sapropterini Dihydrochloridum 100 mg
Dipharma SA
B / SL / SG
FB
G
L
IP
CI
Sapropterin Dipharma 100 mg
120
2791.88
3052.75
10 %
compressa dispersibile: Sapropterini Dihydrochloridum 100 mg
Dipharma SA
B / SL / SG
FB
G
L
IP
CI
Sapropterin Dipharma 100 mg
30
808.62
897.15
10 %
polvere per soluzione orale: Sapropterini Dihydrochloridum 100 mg
Dipharma SA
B / SL / SG
FB
G
L
IP
CI
Sapropterin Dipharma 500 mg
30
2979.15
3256.40
10 %
polvere per soluzione orale: Sapropterini Dihydrochloridum 500 mg
Dipharma SA
B / SL / SG
FB
G
IP
CI
Kuvan
30 Tablet(s)
k.A.
Tablets: Sapropterini Dihydrochloridum 100 mg
DRAC AG
B
FB
G
IP
CI
Kuvan
120 Tablet(s)
k.A.
Tablets: Sapropterini Dihydrochloridum 100 mg
DRAC AG
B
FB
G
Sapropterin NOBEL 100 mg
30
k.A.
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
NOBEL Pharma Schweiz AG
B
FB
G
IP
CI
Sapropterin Spirig HC 100 mg
30
k.A.
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
Spirig HealthCare AG
B
FB
G
IP
CI
Sapropterin Spirig HC 100 mg
120
k.A.
Tabletten zur Herstellung einer Lösung zum Einnehmen: Sapropterini Dihydrochloridum 100 mg
Spirig HealthCare AG
B
FB
G
Eliglustat (A16AX10) 3 products
WHO-DDD
DrugBank.ca
Page 1 of 2:
1
2
>>
L
IP
CI
Cerdelga 84 mg
56
25084.71
26044.70
10 %
Capsules: Eliglustatum 84.4 mg
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
CI
Cerdelga 84 mg
14
k.A.
Capsules: Eliglustatum 84.4 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
Cerdelga 84 mg
196
k.A.
Capsules: Eliglustatum 84.4 mg
Sanofi-Aventis
(Suisse) SA
B
FB
G
Migalastat (A16AX14) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
L
IP
CI
PP
Galafold 123 mg
14
17664.59
18431.65
10 %
Capsules: Migalastatum 123 mg
Amicus Therapeutics
Switzerland GmbH
B / SL
FB
G
Lumasiran (A16AX18) 1 products
WHO-DDD
Page 1 of 2:
1
2
>>
IP
CI
Oxlumo 94.5 mg / 0.5 ml
k.A.
Alnylam Switzerland
GmbH
B
FB
G
Homöopathika für Verdauungstrakt und Metabolismus (A16AZ) 41 products
WHO-DDD
Page 1 of 2:
1
2
>>
CI
H
Cuprukehl D4
10 1 ampoule(s) à 2 ml
17.50
k.A.
Injection solution: Cuprum Gluconicum D4 Aquos (Hab 5A, 5B) 2 ml
ebi-pharm ag
B
FB
G
CI
H
Fortakehl D5
10 1 ampoule(s) à 1 ml
63.00
k.A.
Injection solution: Penicillium Roqueforti Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Fortakehl D5
50 1 ampoule(s) à 1 ml
251.00
k.A.
Injection solution: Penicillium Roqueforti Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Cand D5
10 1 ampoule(s) à 1 ml
k.A.
Injection solution: Candida Albicans Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Cand D5
50 1 ampoule(s) à 1 ml
k.A.
Injection solution: Candida Albicans Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Salm D6
10 1 ampoule(s) à 1 ml
k.A.
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Salm D6
50 1 ampoule(s) à 1 ml
k.A.
ebi-pharm ag
B
FB
G
CI
H
Fortakehl D3
10 suppositories
21.30
k.A.
Suppositories: Penicillium Roqueforti D3 Trituratio 200 mg
ebi-pharm ag
D
FB
G
CI
H
Similasan Magen-Darm-
Beschwerden
15 g
k.A.
Globules: 4 Active Agents
Similasan AG
D
FB
G
CI
H
Similasan Magenbrennen
15 g
k.A.
Globules: 3 Active Agents
Similasan AG
D
FB
G
CI
H
Toxex
10 g
k.A.
Globules: 8 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Fortakehl D4
20 Capsule(s)
43.50
k.A.
Capsules: Penicillium Roqueforti D4 Trituratio 330 mg
ebi-pharm ag
D
FB
G
CI
H
Fortakehl D5
20 Tablet(s)
16.00
k.A.
Tablets: Penicillium Roqueforti D5 Trituratio 250 mg
ebi-pharm ag
D
FB
G
CI
H
Gastricumeel
50 Tablet(s)
8.90
k.A.
Tablets: 5 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Similasan Magenbrennen
60 Tablet(s)
k.A.
Tablets: 3 Active Agents
Similasan AG
D
FB
G
CI
H
Cuprukehl D3
30 ml
10.80
k.A.
Drops: Cuprum Gluconicum D3 80 µl/ml
ebi-pharm ag
B
FB
G
CI
H
Cuprukehl D3
100 ml
21.20
k.A.
Drops: Cuprum Gluconicum D3 80 µl/ml
ebi-pharm ag
B
FB
G
CI
H
Fortakehl D5
10 ml
15.50
k.A.
Drops: Penicillium Roqueforti Aquos D5 Dilutio
ebi-pharm ag
D
FB
G
CI
H
Okoubasan
30 ml
k.A.
ebi-pharm ag
D
FB
G
CI
H
Toxex
50 ml
k.A.
Drops: 7 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Toxex
100 ml
k.A.
Drops: 7 Active Agents
ebi-pharm ag
D
FB
G
CI
Selomida Verdauung
12 x 7.5 g
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Selomida Verdauung
30 x 7.5 g
k.A.
Pulvermischung: 6 Active Agents
Schwabe Pharma AG
D
FB
G
CI
Gemmo Magenbeschwerden
30 ml
k.A.
Spray zur Anwendung in der Mundhöhle: Ficus Carica e Gemma Recenti D1 (Ph.Eur.Hom. 2.1.3) 1 ml
Spagyros AG
D
FB
G
CI
H
Defaeton
50 ml
15.70
k.A.
Tropfen zum Einnehmen: 5 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Mucan
100 ml
k.A.
Tropfen zum Einnehmen: 7 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Sanukehl Cand D6
10 ml
k.A.
Tropfen zum Einnehmen und Einreiben: Candida Albicans Extractum Cellulae (Lyophil., Steril.) D6 (Hab 5A) 1 ml
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Salm D6
10 ml
k.A.
Tropfen zum Einnehmen und Einreiben: Salmonella Enteritidis Extractum Cellulae (Lyophil., Steril) D6 (Hab 5A) 1 ml
ebi-pharm ag
B
FB
G
CI
H
Dr. Reckeweg R 5 Gastreu
50 ml
k.A.
gouttes buvables: 10 Active Agents
Laboratoire Jacques
Reboh et fils SA
D
FB
G
CI
H
Dr. Reckeweg R 32
Antihidrosin
50 ml
k.A.
gouttes buvables: 8 Active Agents
Laboratoire Jacques
Reboh et fils SA
D
FB
G
CI
H
Cuprukehl D4
50 1 ampoule(s) à 2 ml
71.00
k.A.
Injection solution: Cuprum Gluconicum D4 Aquos (Hab 5A, 5B) 2 ml
ebi-pharm ag
B
FB
G
CI
H
Fortakehl D5
ampoule(s) à 1 ml
9.20
k.A.
Injection solution: Penicillium Roqueforti Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Sanukehl Cand D5
ampoule(s) à 1 ml
k.A.
Injection solution: Candida Albicans Aquos D5 Dilutio
ebi-pharm ag
B
FB
G
CI
H
Similasan Magen-Darm-
Beschwerden
4.5 g
k.A.
Globules: 4 Active Agents
Similasan AG
D
FB
G
CI
H
Similasan Magenbrennen
4.5 g
k.A.
Globules: 3 Active Agents
Similasan AG
D
FB
G
CI
H
Apo-Stom
50 ml
15.70
k.A.
Tropfen zum Einnehmen: 6 Active Agents
ebi-pharm ag
D
FB
G
CI
H
Mucan
50 ml
k.A.
Tropfen zum Einnehmen: 7 Active Agents
ebi-pharm ag
D
FB
G
Gasterophyl
15 ml
6.20
k.A.
Drops: 9 Active Agents
Laboratoire Dr. E.
Homberger SA
C
FB
G
Gasterophyl
30 ml
10.30
k.A.
Drops: 9 Active Agents
Laboratoire Dr. E.
Homberger SA
C
FB
G
Gasterophyl
60 ml
18.60
k.A.
Drops: 9 Active Agents
Laboratoire Dr. E.
Homberger SA
C
FB
G
Phytopharma
100 ml
k.A.
Drops: Cynara Scolymus Tm
Phytopharma SA
D
FB
G
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home